Guelph, ON—Nutrasource Pharmaceutical and Nutraceutical Services is rebranding its clinical trial site. The newly namedApex Trialsis a premium clinical trial site, conducting studies in both the pharmaceutical and nutraceutical industries, according to the company's announcement. Apex Trials focuses primarily on Phase I / Pharmacokinetic studies – Phase IV Studies for both Pharmaceutical and Nutraceuticals.“We are excited to launch our clinical trial site under the brand of Apex Trials,” said Joshua Baisley, SVP Clinical Operations, in the press release. “We deliberately separated the operations of our site from our CRO activities many years ago to differentiate ourselves from our competitors and demonstrate our commitment to compliance thereby protecting our Sponsor’s investment. With a team of over 20 staff, 20 years of clinical trial experience, and a client-centric approach.”
Apex Trials will focus on studies targeting:
- Cardiovascular disease
- Hypertension
- Dyslipidemia
- Diabetes
- Irritable bowel syndrome
- Weight management
- Emergency Medicine Specialist
- Nurse Practitioners
- Clinical Research Coordinators
- MLPAO / CSMLS Certified Medical Laboratory Professionals
- Pharmacy Staff (QPIC and A/QPIC)
- Quality Assurance and Quality Control Personnel
- Dedicated Participant Recruitment Team
Associations represented across the team include SOCRA, SCRS, SQA, N2 Network of Networks, and CITI Program.
"Over the past decade, I have been able to witness and appreciate the evolution of our clinical trials unit. I am very proud of the team for accepting and embracing all the physical and procedural changes we have implemented over the years benefiting both our clients and our participants,” said Katie Keene, Clinic Supervisor, in the release. “This latest change is our biggest and best yet as it will allow us to expand our focus beyond food and natural health product trials to include pharmaceutical trials, further growing our site’s portfolio of offerings.”
